Skip to content
Company Analysis

Stryker Corporation SYK

A comprehensive view of key metrics, scores, and financial health for Stryker Corporation

Overview of Stryker Corporation

SYK NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Large Cap
Stryker Corporation (SYK), is a Large Cap company, in the Medical Devices industry, last closed at $312.20, about 63.6% overvalued vs fair value, -17.3% 1Y return, placing in the top 10% of its sector.
Metrics P/E 41.8× Rev Growth 11.2% ROE 15.1% Gross Margin 64.0% Div Yield 0.96%
USD 312.20
2.15%
(Delayed)
• Vol 90d: 27.8%
52-Week Range
Market Cap
$118.40B
Enterprise Value
$130.25B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Good
Valuation
Good
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Good
Valuation
Good
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.stryker.com
HQ Portage, MI
Employees 56,000
Fiscal year Dec 31

Next Events

Earnings Jul 30 Estimated
Dividend Jul 31 Ex-div: Jun 30

Fair Value Snapshot

Bear Base Bull
$101
$114
$127
Current: $312.20 -64% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$25.1B
11.2%%
Gross Profit
$16.1B
11.3%%
Operating Income (GAAP)
$5.1B
8.4%%
EBITDA
$6.3B
27.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
64.0%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Stryker Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
74
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
79
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing SYK's balance between Growth (26.4%), Profitability (40.0%), and Safety (33.6%). Growth 26% Safety 34% Profitability 40%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

54th percentile vs peers
55
Key Signals
Rev Growth YoY 11.2% 59p Revenue CAGR 3Y 10.8% 58p EPS CAGR 3Y 10.8% 61p EPS Growth YoY 8.2% 38p TSR -1.5% 47p
Strengths
  • FCF Margin in top 20% of peers (17.1%, 90th percentile)
  • Operating Margin in top 20% of peers (20.1%, 90th percentile)
  • ROIC in top 20% of peers (9.5%, 85th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (37.90, 99th percentile)
Risks

No significant risks identified for this axis.

Profitability

83th percentile vs peers
83
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

70th percentile vs peers
70
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Stryker Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$113.52
- - -
-63.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000